首页 | 本学科首页   官方微博 | 高级检索  
检索        

伊班膦酸钠联合化疗治疗转移性骨肿瘤45例疗效观察
引用本文:张长弓,张勇,李高峰.伊班膦酸钠联合化疗治疗转移性骨肿瘤45例疗效观察[J].肿瘤基础与临床,2008,21(6).
作者姓名:张长弓  张勇  李高峰
作者单位:云南省肿瘤医院胸外科,云南,昆明,650118
摘    要:目的 探讨伊班膦酸钠(艾本)联合化疗治疗恶性肿瘤骨转移的临床疗效.方法 45例恶性肿瘤骨转移,均用伊班膦酸钠联合化疗.结果 患者疼痛总缓解率为84%,骨病灶控制总有效率为29%,无明显毒副反应.结论 伊班膦酸钠联合化疗是目前治疗晚期恶性肿瘤骨转移的优选方案.

关 键 词:伊班膦酸钠  骨转移  化疗

A Clinical Study of Response of Concurrent Sodium Ibandronate with Chemotherapy in Forty-Five Patients with Cancer and Bone Metastases
Zhang Changgong,Zhang Yong,Li Gaofeng.A Clinical Study of Response of Concurrent Sodium Ibandronate with Chemotherapy in Forty-Five Patients with Cancer and Bone Metastases[J].journal of basic and clinical oncology,2008,21(6).
Authors:Zhang Changgong  Zhang Yong  Li Gaofeng
Institution:Zhang Changgong,Zhang Yong,Li Gaofeng(Department of Thoracic Surgery,Yunnan Tumor Hospital,Kunming 650118,China)
Abstract:Objective To evaluate therapeutic effect of sodium ibandronate with chemotherapy in patients with cancer and bone metastases.Methods All the 45 patients with cancer and bone metastases were received sodium ibandronate combined with chemotherapy.Results The response rate of bone pain relief was 84%.The response rate of bone metastases was 29%.No serious side effect was found in this group.Conclusion Sodium ibandronate combined with chemotherapy is a better method to treat the patients with cancer and bone me...
Keywords:sodium ibandronate  chemotherapy  bone metastases  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号